Form 4: WisdomTree Director Smita Conjeevaram Receives Deferred Equity Award

WisdomTree, Inc. Director Smita Conjeevaram was granted 9,871 restricted stock units (RSUs) as part of her deferred compensation, vesting in June 2026 and payable by June 2027.

Summary

• Smita Conjeevaram, a Director at WisdomTree, Inc. (WT), acquired 9,871 shares of Common Stock through a Restricted Stock Unit (RSU) grant.
• The transaction date for this acquisition was June 17, 2025.
• The RSUs were issued pursuant to the Non-Employee Directors' Deferred Compensation Program under the company's 2022 Equity Plan.
• The acquisition price for these RSUs was $0.0000, indicating they are a compensation award.
• Following this transaction, Ms. Conjeevaram beneficially owns 77,368 shares of Common Stock directly.
• The common stock underlying these RSUs will vest on June 17, 2026.
• The shares are payable on a one-for-one basis (one share of common stock for each RSU) upon the earliest of June 30, 2027, a 'separation from service,' or a qualifying 'Sale Event' as defined by the 2022 Equity Plan and Code Section 409A.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive. While a Form 4 is primarily a disclosure of an insider transaction, the grant of equity compensation to a director is a positive sign of alignment between management/board and shareholder interests, and it's a routine, expected event.

Positives

• The grant of 9,871 Restricted Stock Units (RSUs) to Director Smita Conjeevaram aligns her interests with those of shareholders, as the value of her compensation is tied to the company's stock performance.
• The use of a deferred compensation program indicates a structured approach to director remuneration and potentially tax-efficient planning for the recipient.

Future Outlook

The common stock underlying the granted RSUs is scheduled to vest on June 17, 2026, and will be payable on the earliest of June 30, 2027, a separation from service, or a qualifying Sale Event.

Industry Context

This filing represents a routine equity compensation grant to a non-employee director, a common practice across publicly traded companies in the financial services industry and beyond, aimed at aligning director incentives with long-term shareholder value.

Comparison to Industry Standards

• The grant of Restricted Stock Units (RSUs) as part of non-employee director compensation is a standard practice across the financial industry, including asset management firms like BlackRock, Vanguard, and State Street, which often use equity awards to incentivize long-term commitment and align interests.
• The deferral mechanism, allowing the director to elect deferred receipt, is also a common feature in sophisticated compensation plans, offering tax planning flexibility to executives and directors, similar to programs seen at large financial institutions.
• The vesting schedule (one year out) and payment triggers (fixed date, separation, or change of control) are typical for such awards, mirroring structures found in compensation packages at comparable companies in the asset management sector.

Corporate Governance

Related Party Transactions

• The grant of Restricted Stock Units to Director Smita Conjeevaram constitutes a related party transaction, as it involves compensation from the company to a member of its board of directors. This is a standard and disclosed form of compensation.

Stakeholder Impact

• Shareholders: The equity grant aligns the director's financial interests with the long-term performance of the company, potentially benefiting shareholders through improved governance and strategic decision-making.
• Employees: No direct impact on employees is indicated by this specific filing.

Next Steps

• The common stock underlying the RSUs is scheduled to vest on June 17, 2026.
• The shares are scheduled to be paid out on the earliest of June 30, 2027, separation from service, or a qualifying Sale Event.

Key Dates

Keywords

WisdomTree, WT, Smita Conjeevaram, Restricted Stock Units, RSU, Equity Compensation, Director Compensation, SEC Form 4, Insider Transaction, Deferred Compensation, 2022 Equity Plan